Knudsen Pope M, Hall TS, Virdone S, Atar D, John Camm A, Pieper KS, Jansky P, Haas S, Goto S, Panchenko E, Baron-Esquivias G, Angchaisuksiri P, Kakkar AK, GARFIELD-AF Investigators(2023) Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry Int J Cardiol Heart Vasc, 49, 101302 DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059
Kristensen AMD, Munkhaugen J, Halvorsen S, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Lange T, Fagerland MW, Torp-Pedersen C, Prescott E, Atar D(2023) The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvad093, PubMed 38017624
Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling Cet al.(2023) Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation N Engl J Med(in press) DOI 10.1056/NEJMoa2310234, PubMed 37952132